TNFSF13B and systemic lupus erythematosus: Belimumab, a human anti-BAFF (B-cell activation factor) antibody that selectively depletes mature and activated B cells and PBs and results in an increase in the number of PCs, has been used to treat patients with SLE (14, 15).